FENC logo

Fennec Pharmaceuticals (FENC) Company Overview

Profile

Full Name:

Fennec Pharmaceuticals Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

September 15, 2017

Indexes:

Not included

Description:

Fennec Pharmaceuticals is a biopharmaceutical company focused on developing treatments for rare diseases. They specialize in innovative therapies, particularly for pediatric patients. Their main product, Pedmark, is designed to reduce hearing loss caused by chemotherapy in children. Fennec aims to improve the quality of life for patients.

Key Details

Price

$7.02

Annual Revenue

$21.25 M(+1284.50% YoY)

Annual EPS

-$0.60(+33.33% YoY)

Annual ROE

138.06%

Beta

0.79

Events Calendar

Earnings

Next earnings date:

Mar 21, 2025

Recent quarterly earnings:

Nov 7, 2024

Recent annual earnings:

Mar 21, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Sep 9, 2014

Analyst ratings

Recent major analysts updates

Dec 17, 24 HC Wainwright & Co.
Buy
Aug 22, 24 HC Wainwright & Co.
Buy
Aug 14, 24 Craig-Hallum
Buy
May 15, 24 HC Wainwright & Co.
Buy
May 15, 24 Craig-Hallum
Buy
Apr 4, 24 HC Wainwright & Co.
Buy
Mar 18, 24 Craig-Hallum
Buy
Aug 4, 23 HC Wainwright & Co.
Buy
Jun 21, 23 HC Wainwright & Co.
Buy
Apr 6, 23 Cantor Fitzgerald
Overweight

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Fennec Pharmaceuticals?
  • Does Fennec Pharmaceuticals pay dividends?
  • What sector is Fennec Pharmaceuticals in?
  • What industry is Fennec Pharmaceuticals in?
  • What country is Fennec Pharmaceuticals based in?
  • When did Fennec Pharmaceuticals go public?
  • Is Fennec Pharmaceuticals in the S&P 500?
  • Is Fennec Pharmaceuticals in the NASDAQ 100?
  • Is Fennec Pharmaceuticals in the Dow Jones?
  • When was Fennec Pharmaceuticals's last earnings report?
  • When does Fennec Pharmaceuticals report earnings?
  • Should I buy Fennec Pharmaceuticals stock now?

What is the ticker symbol for Fennec Pharmaceuticals?

The ticker symbol for Fennec Pharmaceuticals is NASDAQ:FENC

Does Fennec Pharmaceuticals pay dividends?

No, Fennec Pharmaceuticals does not pay dividends

What sector is Fennec Pharmaceuticals in?

Fennec Pharmaceuticals is in the Healthcare sector

What industry is Fennec Pharmaceuticals in?

Fennec Pharmaceuticals is in the Biotechnology industry

What country is Fennec Pharmaceuticals based in?

Fennec Pharmaceuticals is headquartered in United States

When did Fennec Pharmaceuticals go public?

Fennec Pharmaceuticals's initial public offering (IPO) was on September 15, 2017

Is Fennec Pharmaceuticals in the S&P 500?

No, Fennec Pharmaceuticals is not included in the S&P 500 index

Is Fennec Pharmaceuticals in the NASDAQ 100?

No, Fennec Pharmaceuticals is not included in the NASDAQ 100 index

Is Fennec Pharmaceuticals in the Dow Jones?

No, Fennec Pharmaceuticals is not included in the Dow Jones index

When was Fennec Pharmaceuticals's last earnings report?

Fennec Pharmaceuticals's most recent earnings report was on Nov 7, 2024

When does Fennec Pharmaceuticals report earnings?

The next expected earnings date for Fennec Pharmaceuticals is Mar 21, 2025

Should I buy Fennec Pharmaceuticals stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions